Literature DB >> 3162707

Existence of two distinct processes of chromosomal evolution in near-diploid colorectal tumors.

M Muleris1, R J Salmon, B Dutrillaux.   

Abstract

The comparison of all the karyotypes established in each of 18 near-diploid colorectal tumors made it possible to reconstruct a clonal evolution and to distinguish between early and late chromosomal aberrations. Because no abnormalities were observed in all tumors, and as even the most frequent changes, i.e., monosomy 17p and monosomy 18, may be present in mosaic, no chromosomal change can be regarded as a common primary event in the carcinogenetic process. However, the repeated occurrence of several changes favors the hypothesis of two karyotypic evolutionary processes. In most tumors, monosomy 17p and 18 were found, and the karyotypic evolution involved mainly several additional monosomies due to unbalanced rearrangements or losses that affect, by order of decreasing frequency, chromosomes 1p, 4, 14, 5q, 6q, 2p, and 11q, as well as gains of chromosomes 20, 8q, 13, 17q, and X. In this group of tumors, the mean number of chromosomes remains close to 46. In the other tumors, either only a monosomy 17p or a monosomy 18 was found and the karyotypic evolution involved essentially trisomies, resulting from gains with, by order of decreasing frequency, a preferential involvement of chromosomes 7, 8q, 13, 17q, 20, X, 2p, 5, and 16, the only additional recurrent deletion affecting chromosome 1p. In these tumors, the mean chromosome number is close to 51. Ten out of 11 polyploid sidelines emerged from monosomic-type tumors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3162707     DOI: 10.1016/0165-4608(88)90310-x

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  10 in total

1.  Karyotype peculiarities of human colorectal adenocarcinomas.

Authors:  L N Konstantinova; E W Fleischman; V I Knisch; A G Perevozchikov; B P Kopnin
Journal:  Hum Genet       Date:  1991-03       Impact factor: 4.132

2.  Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis.

Authors:  Claire M Payne; Cheray Crowley-Skillicorn; Carol Bernstein; Hana Holubec; Harris Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2011-05-03

3.  Cytogenetic, oncogenetic, and histopathologic characteristics of colorectal carcinomas with 17p abnormalities.

Authors:  D Rau; S Neubauer; A Köster; J Giedl; R Sachse; S Landgraf; A Leipold; T Dingermann; E Gebhart
Journal:  Hum Genet       Date:  1992-04       Impact factor: 4.132

4.  Quantity of nuclear DNA in malignancies and benign lymphadenopathies associated with Epstein-Barr virus.

Authors:  T Lehtinen; M Lehtinen; R Aine; K Dammert; P Kulomaa; M Alavaikko; P Leinikki
Journal:  J Clin Pathol       Date:  1989-07       Impact factor: 3.411

5.  Do aggressive subclones within primary colorectal cancer give rise to liver metastases?

Authors:  J R Jass; K Mukawa; P I Richman; P A Hall
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

6.  The TP53 tumour suppressor gene in colorectal carcinomas. I. Genetic alterations on chromosome 17.

Authors:  G I Meling; R A Lothe; A L Børresen; C Graue; S Hauge; O P Clausen; T O Rognum
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640

7.  Molecular cytogenetic analysis of breast cancer cell lines.

Authors:  J M Davidson; K L Gorringe; S F Chin; B Orsetti; C Besret; C Courtay-Cahen; I Roberts; C Theillet; C Caldas; P A Edwards
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

8.  Chromosomal instability in near-diploid colorectal cancer: a link between numbers and structure.

Authors:  Martine Muleris; Alexandra Chalastanis; Nicolas Meyer; Marick Lae; Bernard Dutrillaux; Xavier Sastre-Garau; Richard Hamelin; Jean-Francois Fléjou; Alex Duval
Journal:  PLoS One       Date:  2008-02-20       Impact factor: 3.240

9.  Genetic alterations within the retinoblastoma locus in colorectal carcinomas. Relation to DNA ploidy pattern studied by flow cytometric analysis.

Authors:  G I Meling; R A Lothe; A L Børresen; S Hauge; C Graue; O P Clausen; T O Rognum
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

10.  The relative timing of mutations in a breast cancer genome.

Authors:  Scott Newman; Karen D Howarth; Chris D Greenman; Graham R Bignell; Simon Tavaré; Paul A W Edwards
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.